VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Q3 Financials same same

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Nov 29, 2023 10:23pm

83 Views

Post# 35760179

RE:Q3 Financials same same

GrahamB....you're still here despite not owning a single share in VPT? Interesting that you are the first to post after financials released. It's like a vulture circling their prey. True shareholders haven't even had any time to read and analyze the interim financials, and yet there you are, the non-shareholder vulture, making the first statement, right out of the gate. Yolou are worse than the bottom-feeding lawyers that I have had the displeasure to know. A true waste of human skin!

<< Previous

Bullboard Posts

Next >>

Report: New, more dangerous malware used in increasing cyberattacks